# Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention and Treatment of Recurrent Urinary Tract Infections

> **NCT06857565** · NA · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 84 (actual)

## Conditions studied

- Recurrent Urinary Tract Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus crispatus M247
- **DIETARY_SUPPLEMENT:** iNatal-Duo® (containing Bifidobacterium animalis subsp. lactis BB-12 and Enterococcus faecium L3)

## Key facts

- **NCT ID:** NCT06857565
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-05
- **Primary completion:** 2026-04-11
- **Final completion:** 2026-04-11
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06857565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06857565, "Study to Evaluate the Efficacy of Lactobacillus Crispatus M247 in the Prevention and Treatment of Recurrent Urinary Tract Infections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06857565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*